Information  X 
Enter a valid email address

APQ Global Limited (APQ)


Wednesday 13 January, 2021

APQ Global Limited

Issue of Equity and PDMR - Correction Statement

RNS Number : 6054L
APQ Global Limited
13 January 2021

13 January 2021

APQ Global Limited

("APQ Global" or the "Company")


Issue of Equity and PDMR/Director Shareholding - Correction Statement


APQ Global Limited, an emerging markets growth company based in Guernsey, announces that, further to the statement it made on 12 January 2021, in respect of the further issue of 26,578 ordinary shares of no par value in the capital of the Company to employees as part of the 2018 management share-based compensation scheme, the Company confirms the correct admission date is 15 January 2021.




For further enquiries, please contact:

APQ Global Limited
Bart Turtelboom

020 3478 9708

N+1 Singer - Nominated Adviser and Broker
James Maxwell / Justin McKeegan

020 7496 3000

Carey Group - TISE sponsor
Claire Torode

01481 737 279

Investor Relations

    [email protected]


Notes to Editors

APQ Global Limited

APQ Global (ticker: APQ LN) is an investment company incorporated in Guernsey. The Company focuses its investment activities globally (in Asia, Latin America, Eastern Europe, the Middle East and Africa, particularly).The objective of the Company is to steadily grow its earnings to seek to deliver attractive returns and capital growth through a combination of building growing businesses as well as earning revenue from income generating operating activities in capital markets1. APQ Global run a well-diversified and liquid portfolio, take strategic stakes in selected businesses and plan to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets. For more information, please visit .

1 Where we refer to revenue from income generating operating activities this relates to the revenue of our investee companies.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t